TITAN PHARMACEUTICALS INC Quarterly Operating Income (Loss) in USD from Q2 2010 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Titan Pharmaceuticals Inc quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q2 2024.
  • Titan Pharmaceuticals Inc Operating Income (Loss) for the quarter ending June 30, 2024 was -$2.07M, a 30.6% decline year-over-year.
  • Titan Pharmaceuticals Inc Operating Income (Loss) for the twelve months ending June 30, 2024 was -$7.13M, a 16.5% increase year-over-year.
  • Titan Pharmaceuticals Inc annual Operating Income (Loss) for 2023 was -$7.28M, a 28.9% increase from 2022.
  • Titan Pharmaceuticals Inc annual Operating Income (Loss) for 2022 was -$10.2M, a 9.42% decline from 2021.
  • Titan Pharmaceuticals Inc annual Operating Income (Loss) for 2021 was -$9.35M, a 27.2% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$7.13M -$2.07M -$486K -30.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-15
Q1 2024 -$6.64M -$1.06M +$634K +37.4% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 -$7.28M -$1.53M +$1.09M +41.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 -$8.36M -$2.47M +$176K +6.66% Jul 1, 2023 Sep 30, 2023 10-K 2024-04-01
Q2 2023 -$8.54M -$1.59M +$854K +35% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-15
Q1 2023 -$9.39M -$1.7M +$842K +33.2% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 -$10.2M -$2.61M -$122K -4.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 -$10.1M -$2.64M -$735K -38.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 -$9.38M -$2.44M -$117K -5.03% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$9.26M -$2.54M +$93K +3.53% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$9.35M -$2.49M +$73K +2.85% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$9.43M -$1.91M -$712K -59.5% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 -$8.72M -$2.33M -$707K -43.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 -$8.01M -$2.63M -$657K -33.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$7.35M -$2.56M -$7.74M -150% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 $385K -$1.2M +$2.69M +69.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$2.3M -$1.62M +$3.26M +66.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$5.57M -$1.98M +$2.31M +53.9% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$7.88M $5.17M +$8.44M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 -$16.3M -$3.88M -$1.93M -98.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 -$14.4M -$4.88M -$4.24M -664% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 -$10.1M -$4.29M -$1.88M -78% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q4 2018 -$8.26M -$3.27M +$108K +3.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-30
Q3 2018 -$8.37M -$1.95M +$2.12M +52% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 -$10.5M -$639K +$2.98M +82.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 -$13.5M -$2.41M +$1.03M +30% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-15
Q4 2017 -$14.5M -$3.37M -$120K -3.69% Oct 1, 2017 Dec 31, 2017 10-K/A 2019-04-02
Q3 2017 -$14.4M -$4.07M -$1.45M -55.6% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 -$12.9M -$3.62M -$15.7M -130% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $2.74M -$3.44M -$1.61M -87.7% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $4.34M -$3.25M -$1M -44.6% Oct 1, 2016 Dec 31, 2016 10-K/A 2019-04-02
Q3 2016 $5.35M -$2.62M -$814K -45.2% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $6.16M $12M +$13.1M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 -$6.98M -$1.83M -$216K -13.4% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-10
Q4 2015 -$6.76M -$2.25M -$997K -79.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-04-02
Q3 2015 -$5.76M -$1.8M -$1.06M -144% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$4.7M -$1.09M -$542K -98.5% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$4.16M -$1.62M -$681K -72.9% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$3.48M -$1.25M -$611K -95.2% Oct 1, 2014 Dec 31, 2014 10-K 2017-03-16
Q3 2014 -$2.86M -$738K -$610K -477% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-16
Q2 2014 -$2.25M -$550K -$258K -88.4% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-13
Q1 2014 -$2M -$934K -$1.11M -646% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-13
Q4 2013 -$891K -$642K -$200K -45.2% Oct 1, 2013 Dec 31, 2013 10-K 2016-03-15
Q3 2013 -$691K -$128K +$2.53M +95.2% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$3.22M -$292K +$1.45M +83.2% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-13
Q1 2013 -$4.67M $171K +$3.7M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$8.37M -$442K +$324K +42.3% Oct 1, 2012 Dec 31, 2012 10-K 2015-03-31
Q3 2012 -$8.69M -$2.66M -$700K -35.8% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-14
Q2 2012 -$7.99M -$1.74M +$2.46M +58.6% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-14
Q1 2012 -$10.5M -$3.53M +$51K +1.42% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
Q4 2011 -$10.5M -$766K Oct 1, 2011 Dec 31, 2011 10-K 2014-03-31
Q3 2011 -$1.96M -$1.82M -1350% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-09
Q2 2011 -$4.2M -$2.47M -143% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-09
Q1 2011 -$3.58M Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q3 2010 -$135K Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-14
Q2 2010 -$1.73M Apr 1, 2010 Jun 30, 2010 10-Q/A 2011-08-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.